The latest United Kingdom (UK) strategy for rare diseases emphasises the need to empower affected populations to improve diagnosis, intervention, and coordination of care. Families who have a child with a rare chromosome disorder (RCD) are a challenging group to include. We report the findings of 2 large-scale surveys, undertaken by the UK RCD Support Group Unique, of these families' experiences over a 10-year period. Seven stages of the patient journey were examined. From pre-testing, through diagnosis, genetics consultation, clinical follow-up and peer support. Overall, 1158 families replied; 36.4% response rate (2003) and 53.6% (2013).
Analysis of responses identifies significant differences (P < .001) over time with a decrease in results reported face to face (76%-62%), doubling by telephone (12%-22%), improved explanation of chromosome disorder (57%-75%), and increased signposting to peer support group (34%-62%). However, conduct of the consultation raises a number of important questions.
Overall, 28 aspects of the patient journey are recognised as requiring improvement; only 12/28 are currently incorporated in UK service specifications. Involvement of RCD families has identified key service improvements. This approach can empower those affected by such extremely rare disorders, and also enable professionals to design improved services in partnership with "expert families." Further surveys are planned.
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| INTRODUCTION
The United Kingdom (UK) Strategy for Rare Diseases places a strong emphasis on empowering those affected by rare diseases in order to improve diagnosis, intervention, and coordination of care in genetics services. 1 Although the strategy was published in late 2013, implementation plans are still being developed for England in 2017 with a view to being fully actioned in 2020. It is acknowledged that this will require "strengthening the mechanisms and opportunities for meaningful and sustained patient involvement in rare disease service provision."
An important and challenging group to consider when involving those affected by rare diseases will be children with a rare chromosome disorder (RCD). In the United Kingdom, it is estimated that at least 300-500 children are born every year with one of a range of RCDs, widely spread geographically. 2 In comparison to more common and well-studied chromosome disorders like Down syndrome, there is far less information available on the natural history or prognosis for these rare diseases (<5 per 10 000 births). 3 Their extreme rarity means RCD cases can be particularly challenging for genetics services because, in addition to communicating a laboratory diagnosis, professionals also need to support families who frequently experience severe distress combined with high levels of uncertainty. 4 In such a situation, service providers must ensure that parents understand the diagnosis, help families identify effective coping strategies, and address the lack of available evidence. 5, 6 To date, little is known about the experiences of these families, or the degree to which Clinical Genetics Services currently meet their needs. This is an important gap, since the UK strategy emphasises that successful implementation will require "recognising patient groups as key partners" to develop care pathways that incorporate "best practice from the user Although this has significantly improved sensitivity for detection of clinically relevant genomic imbalances, it has also increased the need for comprehensive genetic counselling to ensure accurate clinical interpretation. 13 In the case of RCDs, clinical interpretation will still face a high level of uncertainty about each affected child's health, potential cognitive development, and life span even after there is a definitive diagnosis. [14] [15] [16] In this paper, we present the findings of 2 large-scale surveys which investigated the experiences of UK families who have a child with a RCD over the period [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] . We examined the entire care pathway including provision of pre-test information, diagnosis of RCD, genetic counselling, provision of follow-up information and ongoing support. Analysis of responses at different time points is used to reveal trends and changes over time. The findings should hopefully enable best practice from the user perspective to be more effectively integrated into the implementation phase of the UK Strategy for Rare Diseases.
| Objectives
The study had 3 main objectives:
1. to examine RCD families' experiences along the entire care pathway;
2. to compare differences over 10 years and identify positive or negative changes over time; and 3. to recommend improvements to service provision for this important patient group.
| METHODS

| Survey overview
Two surveys were undertaken using a detailed questionnaire designed by Unique, a UK-based Rare Chromosome Disorder Support Group.
This support group has over 15 300 member families, representing over 17 000 individuals affected by RCDs, in over 100 countries worldwide, with around 1500 new families registering annually. 17 The process for designing the questionnaire is described in Appendix S1. 
| Questionnaire content
Questionnaires collected background information on the family.
Respondents were then asked about their experiences during different stages of the patient journey (see Table 1 ). A separate question asked families to rate the quality of the overall service from a user perspective in terms of the overall service received on a ten-point Likert scale ranging from 1 (worst) to 10 (best), and how helpful overall the genetics counselling service has been since their first appointment (4 categories ranging from "not very helpful" to "very helpful"). 
| Data analysis
Numerical data were summarised using mean and SD or median and range, depending on data distribution. Analysis was based on completed question responses. There was no imputation of missing data, although we investigated to assess as far as is possible that missing data were missing completely at random. Certain descriptive variables with multiple response categories were dichotomized before analysis, for example, whether person communicating diagnosis was "genetics professional" or "non-genetics professional," whether the method of communicating was "in person face-to-face" or "indirect by phone, 
| Recommended improvements
A list of recommended improvements was compiled by knowledgeable family members with direct personal experience of RCD, as well as a clinical geneticist and genetics laboratory scientists. Recommendations were based on analysis of data extracted from the questionnaire responses (with detailed examination of levels, significant changes, or lack of a significant difference over time).
3 | RESULTS 
| Respondents
| Rating of service received
When asked how helpful the genetics counselling service had been since their first appointment, Figure 1A shows views were fairly evenly spread across the 4 categories ranging from "not very helpful"
to "very helpful," although the most common response was "had no 
| Families' experiences over 10 years
Families' experiences of services over time are presented in Table 2 . 
| Pre-testing process
In 2003, only 70.7% (95% CI: 66.4-74.7) of families reported that they had been informed that their child's chromosomes were going to be tested. In 2013, this figure was slightly higher at 73.2% (95% CI: 68.6-77.5) but showed no significant improvement over the 10 years (P = .404). and half were not asked how detailed they would like information 
| Test result communication
| Referral to a genetic specialist
| Conduct of genetic consultation
| Genetic and clinical information provision
Although most respondents could understand the information pro- 
| Genetic service follow-up
Although most families were offered a further meeting to discuss their child's chromosome disorder, one third reported that they were not. There was a slight but non-significant (P = . Nevertheless, very few respondents (7% in both time periods)
reported that they were offered any help to contact other RCD families. 
| Recommended improvements identified
| DISCUSSION
The necessity for patient-reported outcomes (PROs) in clinical genetics services has been identified in a recent review. 7 However, provision of services to families who have a child with a RCD is acknowledged to be exceptionally challenging. [4] [5] [6] There is also limited research evidence. A review of research into clinical genetics services and the patient perspective which identified 102 articles 22 found only one focused on these families. 3 The recommendations identified in this study are novel because they are based on the real-life experiences of over 1000 families living with RCDs. As PROs become more important in performance management and funding of health services, 7 sustained capture of the experiences of such families will be a key challenge. 1 Although a recommendation for "sustained patient involvement in rare disease service provision" was embedded in the UK strategy for rare diseases, the overall strategy implementation plan for England has only recently been announced. 23 The large-scale surveys reported here show that, although families' rating of service quality has improved over time, key aspects of the "patient journey" have not and require improvement. Although agreement on key PROs for genetic services is generally acknowledged to be challenging for RCD cases, 7, 24 our surveys do highlight a number of simple improvements which might be easily introduced and which are indicated elsewhere. For example, a review of guidelines from 18 organisations in 6 countries on communication of Robust procedure, including parents being give information on the possible results from genetic testing including the risk of a non-informative result [1]
Non-genetics clinicians should be educated to recognise when the child's symptoms, including developmental delay, ID, clinical symptoms, behavioural issues etc. indicate that a rare chromosome disorder is a possibility and that genetic testing is appropriate [2, 3] Y n a
Non-clinical professionals, for example, social workers, educators, should be educated to the possibility of a rare chromosome disorder to explain a child's/family's difficulties & to know when to refer families on to a relevant clinician for appropriate assessment for genetic testing [2, 3] N -(b) Testing Genetic testing should be done as quickly as possible, reducing the diagnostic odyssey for these families [14] N -Parents should be informed how long the results will take to come back & why there might be delays, for example, need for further analysis [1] N - Parents' preferences for the means by which the results are given to them should be ascertained at the time of testing [4] [5] [6] [7] [8] [9] [10] [11] N -Results should only ever be given by telephone with the parents' express permission [4] [5] [6] [7] [8] [9] [10] [11] N -Results should never be first revealed in a letter or email, unless requested specifically by parents [4] [5] [6] [7] [8] [9] [10] [11] N -
Results should be given in private, either in the clinician's office or at the family home [4] [5] [6] [7] [8] [9] [10] [11] N -Results should ideally be given when both parents are present or if only one parent is available that they be accompanied by a relative or friend for support [4] [5] [6] [7] [8] [9] [10] [11] 
N -
Results should be given to parents without the affected child or other children present [4- Clinicians should explain the implications of the diagnosis on parents, siblings and the affected child's future reproductive risks and options, including information on how to explain the diagnosis to the child and siblings where appropriate and how to make sure future genetic counselling is offered [16] [17] [18] Y 3 6
All consultations should be conducted in a sensitive, empathetic manner, avoiding jargon and without being rushed [15] N -Clinicians should introduce themselves to parents and explain how long the consultation will last [15] N -Parents should be asked what information, if any, they already have about their child's diagnosis and how detailed they want information to be [16] [17] [18] N -Clinicians should be sure to know at least basic information about the child and the family on first meeting to put the families at ease [15] N -
Clinicians should explain what will happen in consultation, preferably providing families with clear written information beforehand about what to expect [15, 16] Link***, Question number(s) [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] in Table 1 linked to each recommendation; In**, whether recommendation currently included (Y/N) in NHS England service specification for organisations funded to provide specialised medical genetics services; %*, % respondents reporting this was achieved (2013 survey).
genetic information to families concluded that there was a significant gap in terms of the professional's role in assisting clients to find options for continued support. 25 This is a key finding identified from our surveys. Our results also echo evidence from US research which found that parents of children with RCDs were largely disappointed in the counselling they received, although this was only a small-scale study. 3 Although international guidelines for clinical genetics professionals largely cover the professional-client relationship, including respect for the client, maintaining confidentiality, and enabling clients to make informed independent decisions, 26 27 pathways. [36] [37] [38] We recognise that the genetic and genomic testing and service landscape in the United Kingdom is also developing at a tremendous pace, not least because of the 100 000 Genomes project, 39 43 and London. 44 Our study inevitably has a number of limitations that should be borne in mind when considering the findings and subsequent recommendations. First, some bias in responses is likely as participants were recruited from a specialist support group and therefore respondents may be different from other UK families with an RCD child. Second, it is possible that parents in Unique may be more knowledgeable because they are part of a well-established support group and have higher expectations (eg, in terms of the information required) than people who do not belong to such an organisation. Third, although the greatest care was taken in questionnaire design, the validity and reliability of the data cannot be tested independently, as with all surveys which record individuals' views. 19 Finally, there may be recall inaccuracy since, in some instances, the survey requested information from families sometime after the event.
| CONCLUSIONS AND RECOMMENDATIONS
These surveys of Unique members address the lack of data on genetic diagnosis and counselling care pathways experienced by families of children with RCDs. Recommendations are offered in the spirit of constructive collaboration to assist clinicians to best meet the needs of patients and their families. 21 The findings set 
